Speaker

Vanessa Morales-Tirado

Principal Scientist, Research, Abbvie

Vanessa Morales-Tirado, Principal Scientist, Research at Abbvie, is speaking at 10th Dermatology Drug Development Summit (Boston, United States of America, 3–5 Nov 2026) in the session “Workshop A: Hidradenitis Suppurativa: Driving Earlier Intervention & Unlocking Disease Modification in HS to Improve Long-Term Outcomes”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

10th Dermatology Drug Development Summit
3–5 Nov 2026Boston, United States of America
- WorkshopWorkshop A: Hidradenitis Suppurativa: Driving Earlier Intervention & Unlocking Disease Modification in HS to Improve Long-Term OutcomesWith Maria Akerman, Kristie Grebe
- PanelPanel Discussion: Competing Beyond Dupixent: Leveraging Unique Mechanisms of Action & Long-Acting Drugs to Differentiate in the Next Wave of Atopic Dermatitis TherapeuticsWith Kenneth Crook, Akanksha Mittal

More speakers at 10th Dermatology Drug Development Summit

Mudgal Kothekar
Vice President Clinical Development, Sun Pharma Advanced Research Company Ltd.
John Armstrong
Head of Healthcare Banking, Westpark Capital
Frederick Beddingfield
Chief Executive Officer & Director, Rubedo Life Sciences
Dan Brownell
Senior Director, AOBiome
Suryasarathi Dasgupta
Director - Scientific & Precision Medicine Immunology, Abbvie
Patti Giblin
Chief Scientific Officer, Ability Biologics

See all 28 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Vanessa Morales-Tirado, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].